Copyright
©The Author(s) 2017.
World J Clin Oncol. Oct 10, 2017; 8(5): 405-411
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.405
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.405
Table 1 Demographic and response data of the whole study population n (%)
| Factors | Value | |
| Age (yr), mean ± SD | 72.2 ± 10.3 | |
| Gender | M | 91 (70) |
| F | 39 (30) | |
| Total | 130 | |
| Head site | Face | 101 (77.7) |
| Scalp | 29 (22.3) | |
| Total | 130 | |
| Response | Poor | 11 (8.5) |
| Partial | 61 (46.9) | |
| Complete | 58 (44.6) | |
| Total | 130 |
- Citation: Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C. Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp. World J Clin Oncol 2017; 8(5): 405-411
- URL: https://www.wjgnet.com/2218-4333/full/v8/i5/405.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i5.405